Lyell Immunopharma (LYEL) Assets (2020 - 2026)
Lyell Immunopharma (LYEL) reported Assets of $311.15 million for Q2 2026, down 19.3% from $385.45 million a year earlier and down 11.3% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma posted Assets of $340.05 million, down 30.7% from FY2024.
- Assets has declined for four consecutive years, with a five-year compound annual growth rate of -17.8% (FY2020 to FY2025).
- By year, Assets came in at $490.86 million in FY2024 (-34.6%), $750.03 million in FY2023 (-20.0%), $937.56 million in FY2022 (-16.8%) and $1.13 billion in FY2021 (+24.1%).
- The Q2 2026 figure ranks as the lowest quarterly Assets in data going back to Q4 2020.
- Year over year, Assets has now declined in each of the last 17 quarters, with an average decline of 29.8% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 24.1%); the low point was Q2 2025 (a decline of 41.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $350.63 million (Q1 2026), $340.05 million (Q4 2025) and $407.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Lyell Immunopharma | 411.74 Mn | -470.71 Mn | - | 273.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 273.85 Mn |
| Jun 30, 2026 | 311.15 Mn |
| Mar 31, 2026 | 350.63 Mn |
| Dec 31, 2025 | 340.05 Mn |
| Sep 30, 2025 | 407.97 Mn |
| Jun 30, 2025 | 385.45 Mn |
| Mar 31, 2025 | 429.80 Mn |
| Dec 31, 2024 | 490.86 Mn |
| Sep 30, 2024 | 619.22 Mn |
| Jun 30, 2024 | 654.14 Mn |
| Mar 31, 2024 | 694.22 Mn |
| Dec 31, 2023 | 750.03 Mn |
| Sep 30, 2023 | 794.99 Mn |
| Jun 30, 2023 | 835.35 Mn |
| Mar 31, 2023 | 880.45 Mn |
| Dec 31, 2022 | 937.56 Mn |
| Sep 30, 2022 | 977.27 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.13 Bn |
API Access
Lyell Immunopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();